Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMMUNOGLOBULIN G
- A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
- Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
- Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
- Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment
- A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion
- Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
- Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
- A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
- Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura
- A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- A Ph 2 Study of Glofitamab Alone or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation
- Cupping Therapy on Immune System in Post Covid -19
- A Study of AK127 Combined With AK104 in Patients With Advanced Malignant Tumors
- A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
- Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
- Add-on Intravenous Immunoglobulins in Early Myositis
- Anti-CD20 Antibodies for Treatment of SLE-PAH
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 in Patients With Advanced Solid Tumors
- First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Radiofrequency Ablation in Combination With Lenvatinib and Sintilimab
- Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
- A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
- An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases.
- Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
- Avatrombopag Combined With IST as First-line Treatment for SAA
- Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer
- A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
- Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
- A Phase I/II Study of Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
- Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus
- Therapies for Down Syndrome Regression Disorder
- Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
- A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
- A Study of AK129 in Patients With Advanced Malignant Tumors
- A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
- IVIg Plus Low Dose rhTPO for ITP in Pregnancy
- Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)
- Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound
- Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
- Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies
- Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
- Immunomodulatory Therapy in Women With Autoimmune Premature Ovarian Insufficiency
- IVIG vs SCIG in CIDP
- A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
- Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
- A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
- A Phase 3 Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
- A Study to Learn About the Study Medicine (Called TTI-622) in Japanese With Difficult to Manage Type of Lymphoma
- Phase 1/2a Open-label Trial of BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors
- Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
- Phase I Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
- Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
- Preliminary Analysis of Recurrent/Metastatic Nasopharyngeal Carcinoma Patients: a Phase II Study
- B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
- GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT
- A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias
- A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)
- A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
- Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
- Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
- PT886 For Treatment of Patients With Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinomas
- Geisinger Antibiotic Allergy Pilot Program: Assess and Address
- A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma
- The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy
- Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects
- Durvalumab and Tremelimumab in Resectable HCC
- Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2
- A Study of Daratumumab
- Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults
- Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
- Omalizumab Efficacy in Patients With Refractory Nasal Polyps
- Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19)
- A Study of Lazertinib and Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
- Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
- A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
- A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
- Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
- A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
- Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
- A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies
- Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
- Application of Artemisia Pollen Specific Allergen Immunotherapy in Patients With Allergic Rhinitis in Autumn
- B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
- Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study
- A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
- A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants
- A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies
- A Study of Ustekinumab in Pediatric Participants
- A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
- Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
- Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)
- Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women
- A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus Infection
- A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
- A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
- Loncastuximab Tesirine in WM
- Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
- Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19
- A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
- Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients
- Vitamin D Improves Clinical Manifestations in Asthmatic Children
- Evaluation of IGM-6268 in Healthy Volunteers
- Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
- Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
- Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
- Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
- Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
- Isatuximab in Type I Cryoglobulinemia
- IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
- Study of ALXN2050 in Proliferative Lupus Nephritis (LN) and Immunoglobulin A Nephropathy (IgAN)
- The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population
- Study for Desensitization of Chronic Kidney Disease Adult Patients in Need of a Kidney Transplant Who Are Highly Sensitized to Human Leukocyte Antigen
- A Study of Ustekinumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
- COVID-19 VaccinE Response in Rheumatology Patients
- Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- ACALA-R In Anti-MAG Neuropathy Mediated Neuropathy
- A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation
- Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
- Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Stop Hep B @ Birth
- A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
- Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Receive
- A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Canc
- Cyclosporine vs Steroids in DRESS
- A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
- In-patient COVID-19 Study of Intranasal Foralumab
- GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
- A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
- IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
- Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
- Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis
- A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
- A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Who
- A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
- A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients
- A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
- A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
- A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
- Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
- Omega-3 Oil Use in COVID-19 Patients in Qatar
- Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease
- Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)
- MBG453 in Lower Risk MDS
- A Phase 1 Study of AV-380 in Healthy Subjects
- Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
- Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
- A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
- Post IVIG Medication in Children With Immune Thrombocytopenia
- Subcutaneous Immunoglobulin for Myasthenia Gravis
- Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
- Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
- Intravenous Immunoglobulin and Prednisolone for RPL After ART.
- Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
- Open-Label Extension Study of BION-1301 in IgA Nephropathy
- Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors
- Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)
- A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
- Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
- A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
- A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
- A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin Who Are Ineligible for or Elected Not to Unde
- A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
- Defining and Treating Depression-related Asthma
- IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
- Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
- Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis
- Open-label Trial of IVIG in Children With PANS
- Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer With HRR Mutation and MSS
- Study to Assess the Effect of Meplazumab on COVID-19
- Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
- Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
- COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
- First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
- Tocilizumab in COVID-19 Lahore General Hospital
- Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
- Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
- A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Inse
- Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
- Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease
- Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis
- Growth Hormone in Obese Cases With Covid-19
- A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)
- Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
- Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study
- PRECISE CURATE.AI Pilot Clinical Trial
- Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
- Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19
- OSIG-eye Drops Treatment for Dry Eye Disease
- Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
- Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment
- The Efficacy of Preseasonal Omalizumab Treatment
- Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
- Head Yuanshi Dian Therapy in Burning Mouth Syndrome
- Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease
- Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA
- Immunogenicity of an Anti-pneumococcal Combined Vaccination in Acute Leukemia or Lymphoma
- A Preventive Treatment for Migrant Workers at High-risk of COVID-19
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
- Effect of Dupilumab on Aspirin Intolerance
- Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients
- Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
- Comparison between2 Drugs in Lupus Nephritis
- Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
- The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma
- Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
- Intermediate IND Severe Illness COVID-19 CP
- IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
- Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
- Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.
- A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
- Oral 25-hydroxyvitamin D3 and COVID-19
- Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
- Randomised Evaluation of COVID-19 Therapy
- Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia
- Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
- A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
- Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)
- Tocilizumab Treatment in Patients With COVID-19
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09
- Polyvalent Immunoglobulin in COVID-19 Related ARds
- Clinical Study of Meplazumab to Treat With Malaria
- Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia
- Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
- A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)
- rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)
- PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients With Intrahepatic Cholangiocarcinoma After Surgery
- Safety and Efficacy Study of VIS649 for IgA Nephropathy
- Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric or Gastro-esophageal Junction Cancer (APICAL-GE)
- Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
- The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
- Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)
- A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
- Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan
- A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma
- Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis
- Desensitization in Kidney Allograft Using Daratumumab
- A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
- Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock.
- SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
- Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia
- Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
- Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma
- IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS or FGFR-3 Antibodies
- Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
- Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI
- A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants
- A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
- A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
- Characterizing IgG4-RD With 68Ga-FAPI PET/CT
- A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
- A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
- Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer
- Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)
- IgM-Enriched Immunoglobulin for Neonatal Sepsis
- A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
- IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
- The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy
- Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)
- A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy
- SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma
- Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
- Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
- Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
- Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
- Burosumab for CSHS
- IVIG-eye Drops Treatment for Dry Eye Disease
- Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive
- Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.
- RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome
- Study of AMG531(Romiplostim) in Patients With Aplastic Anemia
- Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection
- A Study of Imlifidase in Patients With Guillain-Barré Syndrome
- Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
- Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
- IVIG (Gamunex-C) Treatment Study for POTS Subjects
- Tacrolimus Treatment for Refractory Autoimmune Cytopenia
- CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL
- Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma
- Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux
- A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
- Autologous Transplant To End NMO Spectrum Disorder
- An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments
- Rifaximin in Patients With Monoclonal Gammopathy
- Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
- A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
- Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
- Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
- Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
- Autologous Plasma Treatment for Severe Dry Eye Patients
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
- Bordetella Pertussis Colonisation Challenge Study
- Dupilumab in Chronic Spontaneous Urticaria
- Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome
- Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors
- Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
- Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis
- Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
- SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery
- Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients
- A Dose Escalation and Expansion Study of RO7121661, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
- M7824 in People With Recurrent Respiratory Papillomatosis
- Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy
- Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
- Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab
- The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children
- Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis
- Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
- 124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis
- COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
- The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics
- Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520
- A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
- Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
- A Study of Injection HB002.1T in Subjects With Solid Tumor
- Ixazomib Maintenance Study in Patients With AL Amyloidosis
- Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits
- Treatment of Strongyloides Infection
- Atezolizumab Trial in Endometrial Cancer - AtTEnd
- Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
- Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
- Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
- Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome
- Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
- Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
- Immunotherapy in Autoimmune Encephalitis
- Autologous Gene Therapy for Artemis-Deficient SCID
- Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
- Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
- A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarci
- A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer
- Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical)
- A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
- CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid
- A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC
- Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
- Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation
- Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
- M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas
- Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
- Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates
- Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
- Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft
- A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration
- The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients
- Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
- Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
- Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
- To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
- Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
- Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation
- Intravenous Immunoglobulin for Unverricht-Lundborg Disease.
- Maximizing Outcome of Multiple Sclerosis Transplantation
- A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
- Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
- REduCing Immunogenicity to PegloticasE (RECIPE) Study
- Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
- Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
- Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
- Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
- Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig
- Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in HIV-Infected Infants Receiving Combination Antiretroviral Therapy
- Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
- A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)
- IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
- Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients
- Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis
- Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure
- Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
- Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate
- A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
- Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease
- Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis
- Intraluminal Therapy for Helicobacter Pylori Infection
- Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
- Ixekizumab in the Treatment of Bullous Pemphigoid
- A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
- Effect of Mepolizumab in Severe Bilateral Nasal Polyps
- KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
- Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
- Tocilizumab in Patients With Schnitzler's Syndrome
- Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698
- The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers
- Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1
- Response of the Airway in Sinusitis and Asthma
- Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
- Single Dose Study of ANX005 in Healthy Volunteers
- Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
- The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
- PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
- Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease
- A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia
- a Study of JY09 in Chinese Healthy Subjects
- Immunglobulin M Enriched Intra Venous Immunoglobulin (IVIG) Therapy in Adult Respiratory Distress Syndrom (ARDS) Patients
- Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
- A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy
- The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
- Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies
- Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis
- Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
- Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis
- HyQvia in Multifocal Motor Neuropathy
- IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia
- Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
- Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
- Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
- Tocilizumab in Schizophrenia
- Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
- Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases
- ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
- DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients
- A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
- Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis
- Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
- A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma
- Intravenous Immunoglobulin for Acute Intracranial Hemorrhage
- A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
- Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy
- Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia
- Allergic Rhinitis, Immunotherapy and Vitamin d
- Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
- Treatment of IgG4-Related Disease With Revlimid and Rituximab
- Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
- IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
- Ig PRx in AECOPD: Pilot Study
- POTS Adrenergic Ab (CIHR Aims #1&2)
- Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children
- A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis
- Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis
- A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
- Use of F-652 in Patients With Alcoholic Hepatitis
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
- An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
- Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy
- Pembrolizumab (MK-3475) in MM Patients With Residual Disease
- Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission
- Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL
- Multi Immunotherapy to Test Tolerance and Xolair
- Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment
- Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
- A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
- Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis
- Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
- Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
- PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
- Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
- A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
- Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA
- The Research of Standard Diagnosis and Treatment for Severe HSP in Children
- Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
- Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
- Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
- Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia
- Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
- Preschool Wheeze: Inflammation/Infection Guided Management
- Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
- WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy
- Preoperative Use of Montelukast Sodium
- JET-GBS - Japanese Eculizumab Trial for GBS
- Prospective Study of Patients With Thrombocytopenia Following HSCT
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
- Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis
- Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial
- Subcutaneous Immunoglobulin for CIDP
- Replacement of Lamivudine by Telbivudine to Improve Renal Function
- Grass Pollen Subcutaneous Immunotherapy in Elderly Patients
- Different Doses of IVIG for Kawasaki Disease
- Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation
- IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
- Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
- A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
- Anakinra and Kawasaki Disease
- Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
- Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With Immunoglobulin A Nephropathy on Stable RAAS Blockade
- Rituximab (RTX) Therapy in Patients With Active TAO
- Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
- IVIg for Demyelination in Diabetes Mellitus
- Prednisone in Chronic Rhinosinusitis Without Nasal Polyps
- Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
- Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease
- Single-Dose Study of MT203
- Airway Inflammation in Children With Allergic Rhinitis and Intervention
- Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study
- SUBLIVAC FIX Mite Mixture Dose Tolerability Study
- Immunotherapy and Paraneoplastic Neurological Syndromes
- Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
- Prevention for Mother-to-infant Transmission of HBV
- Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
- Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis
- Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
- Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
- Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
- Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
- Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia
- Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
- Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study
- A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics
- Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
- Effect of Intralymphatic Immunotherapy
- Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)
- Efficacy and Safety of Losartan in Children With Ig A Nephropathy
- Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
- Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
- Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
- Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
- A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage
- Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
- UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered Trametinib
- Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer
- Belatacept in Kidney Transplantation of Moderately Sensitized Patients
- ASIS for GAMMAGARD in Primary Immunodeficiency
- Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation
- Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
- Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation
- Immunoglobulin Dosage and Administration Form in CIDP and MMN
- Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
- Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
- Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma
- a Single-center Registered Clinical Research of Chinese Patients With Moderate to Severe Crohn's Disease
- An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
- Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
- Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
- Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
- Post-bypass Prophylactic IVIG in Infants and Neonates
- Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects
- A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
- The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
- Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
- Compassionate Use of Ibalizumab for the Treatment of HIV Infection
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk Expression in Basophils
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
- Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
- Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
- Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study
- Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL
- IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
- Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml
- Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
- Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- LIME Study (LFB IVIg MMN Efficacy Study)
- A Study of ABT-165 in Subjects With Solid Tumors
- Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
- A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis
- Walnut Oral Immunotherapy for Tree Nut Allergy
- Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)
- Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma
- Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Stem Cell Transplantation for Sickle Cell Anemia
- Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
- Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
- Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
- A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
- Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
- Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
- The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
- Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday
- Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.
- IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
- Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
- A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
- A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
- An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
- Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
- Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
- Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly
- Efficacy and Mechanisms of GLN Dipeptide in the SICU
- Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS
- Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
- Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
- Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
- Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
- Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
- Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
- Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma
- An Open-Label Trial of Tocilizumab in Schizophrenia
- Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
- Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
- Safety and Effect of Doxycycline in Patients With Amyloidosis
- 18F-FDG PET/CT for IgG4-Related Disease
- Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy
- MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
- Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
- Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV
- A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
- H-IVIG Treatment for Severe H1N1 2009
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
- Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
- Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
- Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
- A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
- A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
- Multi-Drug Desensitization Protocol for Heart Transplant Candidates
- Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma
- AMG 386 and Abiraterone for Advanced Prostate Cancer
- IVIG Treatment for Refractory Immune-Related Adult Epilepsy
- Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
- Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
- Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
- Vitamin D and Grass Pollen Specific Immunotherapy
- Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
- Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
- Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia
- Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers
- Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids
- Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
- Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
- Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
- Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloid
- Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Immunoglobulin Levels and Occurrence of Infections After Lung Transplantation and Impact of IgG Replacement
- Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia
- Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg
- GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
- Gemcitabine and CT-011 for Resected Pancreatic Cancer
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
- Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
- Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
- Intravenous Immunoglobulin for PANDAS
- Radioactive Iodide Therapy for Pediatric Graves' Disease
- A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Llama Antibody, Rotavirus Diarrhoea, Children
- Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers
- A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
- Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
- Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies
- High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
- Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial
- Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
- A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
- Phase 2/3 Study of IGSC, 20% in PIDD
- A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma
- Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
- Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
- MEmbranous Nephropathy Trial Of Rituximab
- Milk Oral Immunotherapy in Children to Treat Food Allergy
- Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
- An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
- Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
- Omalizumab in Non-atopic Asthma
- A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
- Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
- Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- An Observational Study of Erbitux® in Patients With Metastatic Colorectal Cancer (mCRC) Refractory to Irinotecan-containing Treatment
- Auto-immunity in Lupus Patients After Influenza Vaccine
- A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
- Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
- Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- Grazax Asthma Prevention
- Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
- A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
- Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
- Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)
- A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
- Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers
- Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
- Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
- Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
- Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
- Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade
- Effect of LY2062430 on the Progression of Alzheimer's Disease
- An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
- Effect of LY2062430 on the Progression of Alzheimer's Disease
- Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
- Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
- Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
- Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
- Aliskiren for Immunoglobulin A (IgA) Nephropathy
- MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Calcitriol in the Treatment of Immunoglobulin A Nephropathy
- Comparison of ATG to Thymoglobuline in Renal Transplantation
- Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy
- Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy
- Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
- Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
- Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
- Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases
- Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.
- Hematopoietic Stem Cell Transplant in Devic's Disease
- Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage
- Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
- Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
- Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
- Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
- Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
- Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
- Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
- The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates
- HD Melphalan and SCT in Patients With IGDD or LCDD
- Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
- IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load
- Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
- Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation
- Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients
- Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
- A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
- Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis
- Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
- Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh
- The Effect of Omalizumab on Responses to Cat Allergen Challenge
- Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
- Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
- Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas
- Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders
- Use of Fenofibrate for Primary Biliary Cirrhosis
- Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
- Rituximab Treatment of Focal Segmental Glomerulosclerosis
- Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
- Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
- CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response
- Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
- Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
- Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
- Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
- Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)
- Safety and Tolerability of Rituximab in Neuromyelitis Optica
- Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
- Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
- Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
- Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor
- A Clinical Study of Intravenous Immunoglobulin
- Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
- Oral Immunotherapy for Childhood Egg Allergy
- Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
- Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
- Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
- Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
- Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia
- Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
- Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
- Research Study of Bipolar Mood Symptoms and Cognitive Problems
- Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
- Rituximab in the Treatment of Idiopathic Membranous Nephropathy
- Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
- BCG Vaccination Delivered Intradermally, Orally and by Combined Routes
- Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
- Subcutaneous Ig NextGen 16% in PID Patients
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
- Therapy for Chronic Cold Agglutinin Disease
- Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
- Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
- Thyroid Treatment Trial
- Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
- Renoprotection in Early Diabetic Nephropathy in Pima Indians
- Etanercept in Hidradenitis Suppurativa
- CVD 909 Vi Prime Boost Study
- GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
- Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
- Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
- Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
- REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
- VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
- Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
- Intravenous Immunoglobulin After Relapse in Vasculitis
- Study of CIDP Patients During IVIG Treatment
- Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease
- Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
- Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
- Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
- STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency
- Efficacy and Mechanisms of GLN Dipeptide in the SICU
- MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
- Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
- A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
- IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
- Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
- Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
- Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)
- Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer
- Alefacept in Patients With Severe Scalp Alopecia Areata
- Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
- Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
- Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
- Efficacy and Safety of IVIG-L in ITP Patients
- Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
- Rituximab in the Treatment of Graves' Disease
- Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
- Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
- Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
- New Challenge Pool of Norwalk Virus Inoculum
- Treatment of Patients With Idiopathic Membranous Nephropathy
- Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation
- Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
- C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
- C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
- Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation
- A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
- Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
- Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
- Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
- A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
- Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis
- Omalizumab to Treat Eosinophilic Gastroenteritis
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
- Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
- BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
- Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease
- IVIG - West Nile Encephalitis: Safety and Efficacy
- Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
- Vitamin A Supplementation in Preterm Infants
- Rituximab to Treat Neuropathy With Anti-MAG Antibodies
- S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
- High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
- B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency
- Vaccine Therapy in Treating Patients With Multiple Myeloma
- Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
- Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
- Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
- Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
- Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
- Study of Human Botulism Immunoglobulin in Infants With Botulism
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
- Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
- Cladribine in Patients With Mantle Cell Lymphoma
- A Study of Isoprinosine in Patients With Lymph Node Disease
- A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
- A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients
- Prevention of RSV Infections in Bone Marrow Transplant Recipients
- Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
- Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
- Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
- Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
- Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
- Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
- The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
- A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
- Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)
- Intravenous Immunoglobulin Therapy in Optic Neuritis
Clinical trials list
click for details